Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.

Becoming a substantial holder

Notification of cessation of securities - CUV

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Clinuvel Pharmaceuticals (CUV AU)

Becoming a substantial holder

Notification of cessation of securities - CUV

SCENESSE dosage expansion under review by EMA

CLINUVEL Bell Potter Healthcare Conference Presentation

CLINUVEL prioritises three strategic programs

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)